Rajeev M. Shah Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rajeev M. Shah.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rajeev M. Shah. Rajeev M. Shah is Director in KalVista Pharmaceuticals, Inc. ($CBYL) and in Kala Pharmaceuticals, Inc. ($KALA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Ra Pharmaceuticals, Inc. ($RARX) and Director in Satsuma Pharmaceuticals, Inc. ($STSA) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Solid Biosciences Inc. ($SLDB) and Director in Eidos Therapeutics, Inc. ($EIDX).
Latest Insider Trading Transactions of Rajeev M. Shah
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BDTX, EIDX, KALA, KALV, RARX, STSA, SLDB
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Option Exercise | A | 12.55 | 15,000 | 188,250 | 15,000 | |
Jun 21 2021 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K | |
May 21 2021 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Sell | J | 24.01 | 443 | 10,636 | 0 | 443 to 0 (-100.00 %) |
Apr 05 2021 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Buy | J | 24.26 | 353,814 | 8,583,528 | 2,277,978 | 1.9 M to 2.3 M (+18.39 %) |
Mar 22 2021 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Grant | A | 24.01 | 443 | 10,636 | 443 | 0 to 443 |
Dec 14 2020 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Grant | A | 3.70 | 4,938,282 | 18,271,643 | 8,709,882 | 3.8 M to 8.7 M (+130.93 %) |
Dec 07 2020 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Option Exercise | A | 4.60 | 20,000 | 92,000 | 20,000 | |
Jun 29 2020 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Jun 18 2020 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
Jun 16 2020 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Option Exercise | A | 26.99 | 10,000 | 269,900 | 10,000 | |
May 29 2020 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | A | 48.51 | 21,528 | 1,044,323 | 21,528 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | D | 19.88 | 15,000 | 298,200 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | D | 9.90 | 15,000 | 148,500 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | D | 22.37 | 15,000 | 335,550 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Sell | D | 48.00 | 4,858,260 | 233,196,480 | 0 | 4.9 M to 0 (-100.00 %) |
Mar 13 2020 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Buy | P | 7.89 | 6,337,135 | 49,999,995 | 10,874,613 | 4.5 M to 10.9 M (+139.66 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 92,063 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 213,429 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 548,224 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 563,204 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 492,643 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 2,885,295 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Buy | P | 19.00 | 136,539 | 2,594,241 | 353,814 | 217.3 K to 353.8 K (+62.84 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Buy | P | 19.00 | 77,803 | 1,478,257 | 311,926 | 234.1 K to 311.9 K (+33.23 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Buy | P | 19.00 | 785,658 | 14,927,502 | 1,924,164 | 1.1 M to 1.9 M (+69.01 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 30,526 | 0 | 217,275 | 186.7 K to 217.3 K (+16.35 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 70,770 | 0 | 234,123 | 163.4 K to 234.1 K (+43.32 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 181,783 | 0 | 1,138,506 | 956.7 K to 1.1 M (+19.00 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 186,749 | 0 | 186,749 | 0 to 186.7 K |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 163,353 | 0 | 163,353 | 0 to 163.4 K |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 956,723 | 0 | 956,723 | 0 to 956.7 K |
Sep 17 2019 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 200,481 | 0 | 0 | |
Sep 17 2019 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 1,139,635 | 0 | 0 | |
Sep 17 2019 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 365,530 | 0 | 0 | |
Sep 17 2019 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 1,642,879 | 0 | 0 | |
Sep 17 2019 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Buy | P | 15.00 | 192,387 | 2,885,805 | 4,681,858 | 4.5 M to 4.7 M (+4.29 %) |
Sep 17 2019 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Buy | P | 15.00 | 1,140,946 | 17,114,190 | 4,489,471 | 3.3 M to 4.5 M (+34.07 %) |
Sep 17 2019 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 200,481 | 0 | 3,348,525 | 3.1 M to 3.3 M (+6.37 %) |
Sep 17 2019 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 365,530 | 0 | 3,148,044 | 2.8 M to 3.1 M (+13.14 %) |
Sep 17 2019 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 1,139,635 | 0 | 2,782,514 | 1.6 M to 2.8 M (+69.37 %) |
Sep 17 2019 | STSA | Satsuma Pharmaceut ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 1,642,879 | 0 | 1,642,879 | 0 to 1.6 M |
Jul 29 2019 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Grant | A | 4.65 | 1,881,720 | 8,749,998 | 4,571,164 | 2.7 M to 4.6 M (+69.97 %) |
Jun 14 2019 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
Jun 13 2019 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
Jun 13 2019 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | A | 30.87 | 21,528 | 664,569 | 21,528 | |
Jun 13 2019 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | A | 19.88 | 15,000 | 298,200 | 15,000 | |
Jun 07 2019 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Option Exercise | A | 5.35 | 21,000 | 112,350 | 21,000 | |
Dec 17 2018 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Option Exercise | A | 23.58 | 8,165 | 192,531 | 8,165 | |
Dec 14 2018 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Buy | P | 15.50 | 1,006,452 | 15,600,006 | 4,858,260 | 3.9 M to 4.9 M (+26.13 %) |
Oct 05 2018 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 4,537,478 | 2.1 M to 4.5 M (+114.72 %) |
Oct 05 2018 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 4,537,478 | 2.1 M to 4.5 M (+114.72 %) |
Jul 26 2018 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Option Exercise | A | 37.89 | 1,835 | 69,528 | 1,835 | |
Jul 03 2018 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | A | 20.34 | 43,056 | 875,759 | 43,056 | |
Jul 02 2018 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | A | 9.90 | 15,000 | 148,500 | 15,000 | |
Jun 22 2018 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 922,950 | 0 | 0 | |
Jun 22 2018 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Buy | P | 17.00 | 1,058,824 | 18,000,008 | 2,162,671 | 1.1 M to 2.2 M (+95.92 %) |
Jun 22 2018 | EIDX | Eidos Therapeutics ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 1,103,847 | 0 | 1,103,847 | 0 to 1.1 M |
Jun 15 2018 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Option Exercise | A | 13.73 | 12,960 | 177,941 | 12,960 | |
Feb 16 2018 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Buy | P | 6.00 | 2,500,000 | 15,000,000 | 3,851,808 | 1.4 M to 3.9 M (+184.94 %) |
Jan 30 2018 | SLDB | Solid Biosciences ... | Shah Rajeev M. | Director | Buy | P | 16.00 | 1,000,000 | 16,000,000 | 2,689,444 | 1.7 M to 2.7 M (+59.19 %) |
Oct 16 2017 | KALV | KalVista Pharmaceu ... | Shah Rajeev M. | Director | Buy | P | 8.50 | 850,000 | 7,225,000 | 1,441,070 | 591.1 K to 1.4 M (+143.81 %) |
Sep 29 2017 | KALV | KalVista Pharmaceu ... | Shah Rajeev M. | Director | Option Exercise | A | 6.71 | 6,000 | 40,260 | 6,000 | |
Jul 26 2017 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 4,409,170 | 0 | 0 | |
Jul 26 2017 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 3,819,444 | 0 | 0 | |
Jul 26 2017 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Buy | P | 15.00 | 533,333 | 7,999,995 | 2,113,236 | 1.6 M to 2.1 M (+33.76 %) |
Jul 26 2017 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 1,579,903 | 0 | 1,579,903 | 0 to 1.6 M |
Jul 21 2017 | KALA | Kala Pharmaceutica ... | Shah Rajeev M. | Director | Option Exercise | A | 15.00 | 12,960 | 194,400 | 12,960 | |
Jun 22 2017 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | A | 22.37 | 15,000 | 335,550 | 15,000 | |
Mar 27 2017 | CBYL | KalVista Pharmaceu ... | Shah Rajeev M. | Director | Option Exercise | A | 7.88 | 12,000 | 94,560 | 12,000 | |
Nov 23 2016 | CBYL | KalVista Pharmaceu ... | Shah Rajeev M. | Director | Grant | A | 0.00 | 591,070 | 0 | 591,070 | 0 to 591.1 K |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 4,015,378 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | C | 0.00 | 4,316,531 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Buy | P | 13.00 | 161,538 | 2,099,994 | 1,351,808 | 1.2 M to 1.4 M (+13.57 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 573,624 | 0 | 1,190,270 | 616.6 K to 1.2 M (+93.02 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Buy | C | 0.00 | 616,646 | 0 | 616,646 | 0 to 616.6 K |
Page: 1